{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:35:03Z","timestamp":1795005303317,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Noninvasive prenatal testing (NIPT) sometimes fails to provide a test result, usually as a result of low cell-free DNA fetal fraction. We investigated how initial fetal fraction, maternal weight, gestational age, and time between blood sampling contribute to obtaining an informative result when a redraw is performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We performed a retrospective data review of NIPT samples received between January and October 2016 by a commercial laboratory, where the initial blood draw did not yield a result and a second sample was drawn between 5 and 28 days after the initial sampling. We included cases with fetal fraction less than 2.8% (the threshold for \u201cno result\u201d in this laboratory) and those with higher fetal fraction but where the NIPT results could not be interpreted with high confidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>For 4,018 cases in which a redraw was recommended, a result was obtained for the second sample in 2,835 cases (70.6%) (95% CI 69.1\u201372.0%). For the 2,959 cases with insufficient fetal fraction, there was a result for the second sample in 1,861 cases (62.9%) (95% CI 61.1\u201364.6%). For this subset, the average increase in fetal fraction was 1.2% with an average interval between draws of 14 days. Informative redraw rate was strongly dependent on maternal weight and fetal fraction measured at the first draw. Gestational age was not an important determinant. Informative redraw rate increased rapidly over the first 8 days after the initial draw and more slowly thereafter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Based on fetal fraction in the initial sample, maternal weight, and interval between blood draws, women can be provided with a personalized estimate of their likelihood of a result on redraw. This should aid in the counseling of women faced with the choice of reattempting NIPT, conventional screening, or an invasive diagnostic test.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000002728","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T11:35:16Z","timestamp":1531308916000},"page":"428-435","source":"Crossref","is-referenced-by-count":44,"title":["Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing"],"prefix":"10.1097","volume":"132","author":[{"given":"Peter","family":"Benn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailen","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Demko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R2-20231015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R3-20231015","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/pd.4640","article-title":"Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing","volume":"35","author":"Helgeson","year":"2015","journal-title":"Prenat Diagn"},{"key":"R4-20231015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cge.13098","article-title":"Clinical experience with a single-nucleotide polymorphism-based noninvasive prenatal test for five clinically significant microdeletions","volume":"93","author":"Martin","year":"2018","journal-title":"Clin Genet"},{"key":"R5-20231015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.12513","article-title":"Non-invasive prenatal testing for aneuploidy: current status and future prospects","volume":"42","author":"Benn","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R6-20231015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/uog.14694","article-title":"A unified approach to risk assessment for fetal aneuploidies","volume":"45","author":"Wright","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R7-20231015","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/oby.2012.138","article-title":"Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women","volume":"20","author":"Haghiac","year":"2012","journal-title":"Obesity"},{"key":"R8-20231015","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pd.4119","article-title":"Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma","volume":"33","author":"Wang","year":"2013","journal-title":"Prenat Diagn"},{"key":"R9-20231015","doi-asserted-by":"crossref","first-page":"527.e1","DOI":"10.1016\/j.ajog.2014.08.006","article-title":"Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing","volume":"211","author":"Dar","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20231015","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pd.5152","article-title":"The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction","volume":"37","author":"Burns","year":"2017","journal-title":"Prenat Diagn"},{"key":"R11-20231015","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216593","article-title":"Repeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt","volume":"2016","author":"Hui","year":"2016","journal-title":"BMJ Case Rep"},{"key":"R12-20231015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/uog.17473","article-title":"Low-molecular-weight heparin associated with reduced fetal fraction subsequent false-negative cell-free DNA test result for trisomy 21","volume":"51","author":"Ma","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R13-20231015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40291-016-0245-9","article-title":"Cell-free fetal DNA for the prediction of pre-eclampsia at the first and second trimesters: a systematic review and meta-analysis","volume":"2","author":"Contro","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"R14-20231015","doi-asserted-by":"crossref","first-page":"231.e1","DOI":"10.1016\/j.ajog.2016.02.009","article-title":"Cell-free DNA fetal fraction and preterm birth","volume":"215","author":"Dugoff","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20231015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pd.4779","article-title":"Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing","volume":"36","author":"Krishna","year":"2016","journal-title":"Prenat Diagn"},{"key":"R16-20231015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000448707","article-title":"Cell-free placental DNA in maternal plasma in relation to placental health and function","volume":"41","author":"Manokhina","year":"2017","journal-title":"Fetal Diagn Ther"},{"key":"R17-20231015","article-title":"Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study","author":"Chan","year":"2017","journal-title":"BJOG"},{"key":"R18-20231015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R19-20231015","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"key":"R20-20231015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pd.4541","article-title":"Circulating cell free DNA testing: are some test failures informative?","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenat Diagn"},{"key":"R21-20231015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/jhg.2016.25","article-title":"Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy","volume":"61","author":"Suzumori","year":"2016","journal-title":"J Hum Genet"},{"key":"R22-20231015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1373\/clinchem.2013.207951","article-title":"Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X","volume":"60","author":"Rava","year":"2014","journal-title":"Clin Chem"},{"key":"R23-20231015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/uog.1923","article-title":"Placental volume measured by three-dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects","volume":"26","author":"Wegrzyn","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R24-20231015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000442931","article-title":"Validation of an enhanced version of a single-nucleotide polymorphism-based noninvasive prenatal test for detection of fetal aneuploidies","volume":"40","author":"Ryan","year":"2016","journal-title":"Fetal Diagn Ther"},{"key":"R25-20231015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma","volume":"64","author":"Lo","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R26-20231015","first-page":":e123","article-title":"Screening for fetal aneuploidy","volume":"127","year":"2016"},{"key":"R27-20231015","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201808000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:47:44Z","timestamp":1786038464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201808000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002728","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}